Since the discovery of SOD1 in 1969, there have been numerous achievements made in our understanding of the enzyme's biochemical reactivity and its role in oxidative stress protection and as a genetic determinant in amyotrophic lateral sclerosis. Many recent advances have also been made in understanding the "activation" of SOD1, i.e. the process by which an inert polypeptide is converted to a mature active enzyme through post-translational modifications. To date, two such activation pathways have been identified: one requiring the CCS copper chaperone and one that works independently of CCS to insert copper and activate SOD1 through oxidation of an intramolecular disulfide. Depending on an organism's lifestyle and complexity, different eukaryotes have evolved to favor one pathway over the other. Some organisms rely solely on CCS for activating SOD1, and others can only activate SOD1 independently of CCS, whereas the majority of eukaryotes appear to have evolved to use both pathways. In this minireview, we shall highlight recent advances made in understanding the mechanisms by which the CCS-dependent and CCS-independent pathways control the activity, structure, and intracellular localization of copper,zinc superoxide dismutase, with relevance to amyotrophic lateral sclerosis and an emphasis on evolutionary biology.
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The Well Conserved Copper-and Zinc-containing Superoxide Dismutase
In a seminal 1969 Journal of Biological Chemistry publication, McCord and Fridovich reported a novel enzymatic activity for erythrocuprein, an abundant copper-containing protein of erythrocytes (1) . Specifically, erythrocuprein was found to disproportionate (both oxidize and reduce) superoxide anions to oxygen and hydrogen peroxide, representing the first description of a superoxide dismutase enzyme. Erythrocuprein is now widely known as SOD1. SOD1 is highly conserved across all eukaryotic phyla and is present in all cells and tissues, where it is believed to act as a first line of defense against toxicity of superoxide anion radicals. The enzyme may also participate in cell signaling where reactive oxygen species have been invoked (2) . Although largely cytosolic, SOD1 also resides in the mitochondrial IMS, 3 where the enzyme can directly remove superoxide generated from the mitochondrial respiratory chain (3, 4) .
In 1993, mutations in human SOD1 were linked to specific familial cases of ALS (5, 6) . This motor neuron disease is not due to a loss of SOD enzymatic activity, but instead mutations throughout the SOD1 polypeptide result in a dominant gain of a toxic property (7) . The precise nature of this toxic property is still not completely clear, and numerous reviews have been published on the topic (8 -12) . Nevertheless, much evidence points to a role for SOD1 misfolding in disease.
SOD1 is normally quite stable, due in large part to copper and zinc binding and oxidation of an intramolecular disulfide (13, 14) . Copper serves as the catalyst for superoxide disproportionation, whereas zinc and the disulfide participate in proper protein folding. SOD1 can be regulated at the post-translational level through copper insertion and disulfide bond formation. We refer to these maturation processes as "SOD1 activation." Currently, there are two main pathways for activating SOD1, and these shall be the focus of this minireview.
Activating SOD1 by the CCS Copper Chaperone
In the mid-1990s, it became evident that certain copper-requiring enzymes needed an ancillary factor to acquire their metal cofactor in vivo. A so-called family of "copper chaperones" was discovered, which act to deliver copper to specific sites in the cell (15) (16) (17) . The first of these identified, "Atx1," delivers copper destined for enzymes in the secretory pathway (18) ; the second, "Cox17," helps supply mitochondrial cytochrome c oxidase with copper (19) ; and the third, which we have named CCS for copper chaperone for SOD1, specifically inserts copper into SOD1 (20) . The first description of yeast and human CCS appeared in the Journal of Biological Chemistry in 1997 (20) , and since then, CCS has been found widely distributed throughout eukaryotes, expressed ubiquitously together with its partner protein, SOD1.
The mechanism by which CCS activates SOD1 has been the subject of numerous reviews (21) (22) (23) , and just a brief synopsis will be provided here. CCS consists of three protein domains (I, II, and III). The central domain II resembles SOD1 and serves to dock CCS with SOD1 (24) . Once the CCS-SOD1 heterodimer has been formed, copper insertion and disulfide oxidation may proceed via a CXC copper-bindingmotifattheC-terminalCCSdomainIII.Inthe CCS-SOD1 docked complex structure solved by Rosenzweig and coworkers (25) , CCS domain III Cys 229 forms an intermolecular disulfide with Cys 57 of SOD1, which is believed to represent the intermediate in forming the SOD1 intramolecular disulfide (see Fig. 2 ).
The most enigmatic of the CCS domains is domain I. This domain harbors a single CXXC copper-binding motif and is a member of the well conserved Atx1 family of copper-binding structures also found in P-type copper-transporting ATPases and in numerous Atx1-like copper chaperones (17, 21) . The CXXC site was originally proposed to bind copper (24, 26, 27) ; however, not all CCS molecules contain this motif, including that of Drosophila (28) and Schizosaccharomyces pombe (29) . Furthermore, mutating the CXXC cysteines did not affect Saccharomyces cerevisiae CCS activity in vivo (28) . Similar findings have been reported for recombinant mammalian CCS in vitro (30) . Although the CXXC motif is not essential, domain I itself is required for CCS activity (24, 29) . Domain I may help CCS dock with an upstream source of copper (see Fig. 2 ).
Mitochondrial SOD1, CCS, and ALS
CCS co-localizes with SOD1 in the mitochondrial IMS and can greatly influence the partitioning of SOD1 between the mitochondria and cytosol (4, 31) . If CCS activates SOD1 in the cytosol, SOD1 is prevented from entering mitochondria. Conversely, if CCS activates SOD1 in the mitochondria, the mature enzyme is retained in the IMS (Fig. 1) . How can CCS and SOD1 enter mitochondria without a mitochondrial targeting presequence? Very recent studies by Hell and co-workers (33) and Kawamata and Manfredi (34) have shown that this occurs through a disulfide relay system involving Mia40.
The Mia40 system for mitochondrial import uses transient intermolecular disulfide bonds to drive the uptake of cysteine-containing proteins into the mitochondrial IMS (32) . CCS, but not SOD1, interacts with Mia40 to form transient disulfides that are subsequently relayed to SOD1, driving uptake of SOD1 into the IMS ( Fig. 1) (33) . In the case of human SOD1, all four SOD1 cysteines are required for mitochondrial uptake of SOD1 (34) . However, the CCS cysteines used in disulfide relay are still unknown and may involve either the domain III CXC or domain I CXXC motif described above.
The CCS control of mitochondrial uptake of SOD1 could have important implications with regard to SOD1-linked ALS. In one hypothesis for the disease, the mitochondrial pool of mutant SOD1 causes damage to mitochondrial function and structure (11) . Mitochondrial uptake of ALS mutant SOD1 is increased upon CCS overexpression (35) ; this CCS-driven uptake of mutant SOD1 results in mitochondrial respiratory defects (36) and, as described below, an acceleration in SOD1-linked motor neuron disease (35, 37) .
Role for CCS in Stability and Folding of Wild-type and ALS Mutant SOD1
CCS can influence SOD1 protein folding and stability. In both Drosophila and Arabidopsis, the Cu,Zn-SOD polypeptide is unstable in cells lacking CCS (28, 38) . By comparison, mammalian wild-type SOD1 is generally stable without CCS; how- In the cytosol, CCS (in blue; step I) interacts with apo-reduced SOD1 (in green; step II) in the presence of copper and oxygen to form enzymatically active SOD1 homodimers (step III) that are prohibited from mitochondrial import. CCS (step I) is also imported into the IMS, where free cysteine thiols on CCS are captured by disulfide-oxidized Mia40 (in orange), forming a CCS-Mia40 complex (step IV) linked by an intermolecular disulfide. Here, the intermolecular disulfide is shown with domain III cysteines of CCS, but may actually involve domain I cysteines. Disulfide rearrangement gives rise to disulfide-oxidized CCS (shown with domain III disulfide, but may be domain I), which is trapped in the IMS. SOD1 enters the mitochondria in the disulfide-reduced and apo state (step II), and IMS-localized SOD1 (step V) reacts with CCS in the presence of copper and oxygen to form an active enzyme (step VI) that cannot escape mitochondria. In cases in which CCS overexpression accelerates SOD1-linked ALS (red arrows), excess cytosolic CCS (step I) somehow leads to an increase in the pool of disulfide-reduced mutant SOD1 (step II), which drives increased mitochondrial import of the SOD1 as described above. The increased SOD1 in the IMS then aggregates (step VII), leading to mitochondrial damage and disease progression. ever, CCS effects become obvious with ALS mutant forms of human SOD1. ALS SOD1 mutants are rapidly degraded when expressed in yeast cells lacking CCS (39) , and in mammalian cell culture, overexpression of CCS can prevent aggregation of ALS mutant SOD1 (40 -42) . On the basis of these findings, one might predict a protective effect of CCS in SOD1-linked ALS. This prediction was put to the test by Elliott and co-workers when they overexpressed CCS in mouse models for SOD1-linked ALS. The results were dramatic and surprising. Rather than being protective, CCS overexpression caused a drastic acceleration in motor neuron disease (35, 37) . CCS overexpression resulted in an increase in disulfide-reduced SOD1 rather than the anticipated increase in disulfide oxidation (37, 40) . Because disulfide-reduced SOD1 is the substrate for mitochondrial import (31), mitochondrial uptake of mutant SOD1 was enhanced (35) . Curiously, there was no obvious SOD1 aggregation in the mice (35, 37, 40) , but recent cell culture studies have indicated that CCS overexpression can lead to increased aggregation of mitochondrial SOD1 without affecting the majority of SOD1 that resides in the cytosol (42) . By leading to enhanced mitochondrial uptake and mitochondrial aggregation of mutant SOD1, overexpression of CCS can accelerate motor neuron disease (Fig. 1) .
Together, these studies underscore the need for an intricate balance between SOD1 and CCS. SOD1 is normally present at a Ն10-fold molar excess over its copper chaperone (22, 43) , which is normally sufficient to maintain SOD1 activity, yet a drastic change in this ratio, such as that obtained in the CCS-overexpressing mouse, can negatively impact on SOD1, particularly in the case of ALS mutants. It is possible that CCS overexpression precludes alternative methods for activating Cu,Zn-SOD such as that described below.
Secondary Means for Activating SOD1 Independently of CCS
When initially discovered in 1997, CCS was believed to represent the sole means for activating Cu,Zn-SOD in vivo. The bulk of the earlier studies were conducted on bakers' yeast SOD1, where ccs1⌬ null strains were seen to express an inactive SOD1 lacking both copper and the intramolecular disulfide (20, 44) . However, when the CCS Ϫ/Ϫ null mouse was created by Wong et al. (45) in 2000, it was noted that a fraction of murine SOD1 retained activity.
FIGURE 2. CCS-dependent versus CCS-independent activation of SOD1.
A, models for SOD1 activation pathways. Left, CCS-dependent activation. Domain I of CCS is hypothesized to dock with an upstream copper source, and copper is captured by the domain III CXC motif. CCS-dependent SOD1 molecules, e.g. S. cerevisiae SOD1, contain Pro 144 , which inhibits SOD1 disulfide oxidation in the absence of CCS and copper. This conformation block by Pro 144 is overcome upon CCS binding and in the presence of molecular oxygen, a transient intermolecular disulfide is formed between CCS, SOD1 is formed, and copper is transferred. The intermolecular disulfide then rearranges to form the SOD1 intramolecular disulfide, producing active SOD1 enzyme. Right, CCS-independent activation of SOD1. The upstream copper source is proposed in this model to directly donate copper to SOD1. CCS-independent SOD1 molecules lack Pro 144 , allowing some disulfide oxidation in the absence of copper, CCS, and oxygen. In this model, no exogenous factor is required for SOD1 disulfide oxidation, and active enzyme is formed immediately upon copper insertion. B, structure of a yeast SOD1 monomer created using Visual Molecular Dynamics v1.8.6 and Protein Data Base code 1SDY and based on published x-ray coordinates (50) . Shown is the close proximity (5.5 Å) of Pro 144 to the intramolecular disulfide bond.
Moreover, this CCS-independent activation of mammalian SOD1 was mirrored in a yeast expression system (46) . It became clear that CCS was not the only way to activate SOD1. Based on the vast homology (54% identity) between yeast and human SOD1, it was surprising that the two enzymes exhibited striking differences in their requirement for CCS. We observed that a single amino acid near the SOD1 C terminus was key. Pro 144 in S. cerevisiae SOD1 is a leucine in human SOD1, and a single P144L (or P144S or P144Q) mutation in yeast SOD1 is sufficient to confer CCS independence to the yeast enzyme (47) . Our most recent studies have shown a role for Pro 144 in controlling the disulfide (see below).
Using Pro 144 as an indicator, we have surveyed the available genome sequences for CCS-dependent SOD1 molecules. Among nearly 270 SOD1 sequences examined across all phyla of plants, animals, fungi, and protists, the vast majority of molecules are seen to contain Leu, Ala, or Val at the corresponding position 144. The occurrence of Pro 144 is extremely rare and restricted to Ascomycota fungi. Even so, Pro 144 is not inclusive of all Ascomycota fungi, as fission yeast SOD1 lacks Pro 144 and indeed shows some CCSindependent activity (29) . Like humans (46) and fission yeast (29) , the Cu,Zn-SOD molecules of the plant Arabidopsis thaliana (38) , Drosophila melanogaster (28), mice (45) , and avians 4 can all be activated with or without CCS, consistent with the absence of Pro
144
. Even so, in all these cases, maximal SOD1 activity is obtained with CCS. CCS may represent the preferred route of enzyme activation, whereas the CCS-independent pathway acts as a backup under conditions in which CCS is limited.
Not All Organisms Use CCS
Although CCS is well conserved between organisms as distant as fungi and mammals, CCS is not present in all eukaryotes. Upon completion of the Caenorhabditis elegans genome, it became clear that this organism lacks an obvious CCS-encoding locus. Using a yeast expression model, we found that the two Cu,Zn-SOD molecules of C. elegans are completely CCSindependent, i.e. they can be activated only by the CCS-independent pathway and will not accept copper from CCS (48) .
The complete independence from CCS may not be unique to C. elegans. An inspection of available genome sequences revealed a striking pattern. Thus far, there have been no CCS-like loci identified in any organism of the Nematoda phylum or in Platyhelminthes (including pathogenic flatworms) for the 17 species with documented Cu,Zn-SODs (Table 1) . Also, none can be identified in mollusks, even though 11 species contain documented Cu,Zn-SOD molecules. In arthropods, CCS is present throughout Insecta, but as of yet, none have been identified in arachnids (Table 1) . By comparison, CCS molecules are found widely distributed throughout all chordates. Although it is difficult to establish an absence of CCS in organisms with incomplete genomes, it is unlikely that C. elegans is the only specie that has evolved complete independence from CCS.
Mechanism of CCS Independence
In an attempt to understand the mechanism of SOD1 activation without CCS, we analyzed the activation patterns for Cu,Zn-SOD molecules that are completely CCS-dependent (S. cerevisiae) and compared them with those that solely use the CCS-independent pathway (C. elegans SOD1) and with those that employ both pathways (human SOD1). Using a yeast expression system, we observed no differences in the apparent kinetics of copper activation, and the CCS-dependent and CCS-independent pathways appear to draw upon the same limited pool of copper (47) . It is possible that the same upstream copper source is used for the two pathways ( Fig. 2A) . Although the pathways could not be distinguished at the level of copper, a striking difference was noted with the disulfide.
The intramolecular disulfide in Cu,Zn-SOD1 is unusual in that the reducing environment of the cytosol tends to maintain protein thiols in the reduced state. In fact, Cu,Zn-SOD bears the only known stable disulfide in the cytosol. In elegant studies by O'Halloran and co-workers (44), the S. cerevisiae SOD1 disulfide was shown to be oxidized by Cu-CCS, yet we recently observed that this is not necessarily true for CCS-independent SOD1 molecules. The disulfide of C. elegans Cu,Zn-SOD is retained in the oxidized state regardless of copper or CCS conditions, and the disulfide of human SOD1 is still Ϸ50% oxidized in the absence of CCS and copper (47) .
We conclude from these studies that CCS is required for those Cu,Zn-SOD molecules that have a low propensity for disulfide oxidation in the reducing environment of the cell. Thus, S. cerevisiae SOD1 is an exception rather than a rule in that its disulfide cysteines are uniquely dependent on Cu-CCS for oxidation. The key to this dependence is the aforementioned Pro 144 in SOD1. The disulfide cysteines of P144S, P144L, and P144Q derivatives of S. cerevisiae SOD1 are readily oxidized in the absence of CCS and copper, similar to what is seen with human SOD1 (47) . This proline lies within 5.5 Å of the disulfide Cys 146 (Fig. 2B ) and may place a conformational restriction on disulfide formation that is overcome only in the presence of Cu-CCS ( Fig. 2A) .
A second important difference between the CCS-dependent and CCS-independent pathways lies in the requirement for molecular oxygen. O'Halloran and co-workers (49) have demonstrated that CCS activation of SOD1 requires molecular oxygen. Surprisingly, however, there is no similar oxygen dependence with CCSindependent activation. We observed CCS-independent activation of human SOD1 even under hypoxic and anoxic conditions (47) . Hence, CCS-independent activation allows SOD1 activity to be maintained over a range of oxygen conditions. This can be particularly critical in tissues of multicellular organisms where oxygen tensions range from near atmospheric to hypoxic.
Why have a vast number of eukaryotes evolved to use dual pathways for activating SOD1 as opposed to just one (e.g. only CCS in bakers' yeast or only the CCS-independent method in nematodes)? The answer may lie in the dual role of SOD1 in oxidative stress protection and cell signaling in higher organisms. At one extreme, the maximal SOD1 activity needed under aerobic conditions and oxidative stress can be achieved through oxygen-regulated CCS. At the opposite extreme, under hypoxic conditions, where oxidative stress is not a concern, the reactive oxygen species products and reactants of SOD can affect cell signaling processes. With low oxygen, SOD1 activity levels are titrated down as needed through a loss of CCS-mediated activation, with the residual SOD1 activity retained through the CCS-independent pathway.
Concluding Remarks
Cu,Zn-SOD is just now celebrating its 40th birthday. Over the decades, this enzyme has made so many benchmarks in the field of reactive oxygen biology, from being the first enzyme known to disproportionate superoxide to being a critical genetic determinant in a fatal motor neuron disease. Although originally believed to be highly active in all cells and tissues, we now know that the activity and structure of the enzyme are quite variable and can be controlled by extrinsic factors, such as oxygen and CCS. The evolutionary biology of SOD1 enzyme activation is in itself an intriguing story, where organisms exhibit the "right to choose" the optimal method for activating SOD1 to fit their complexity and lifestyle. Although a great deal is understood about CCS, the factors for CCS-independent activation of SOD1 are still unknown. It is quite likely that CCS-independent and CCS-dependent pathways use the same source of copper, such as glutathione, and that the only difference lies at the level of disulfide bond oxidation ( Fig.  2A) . In addition, we have only begun to scratch the surface of the role of SOD1 in cell signaling. The enzyme is not just for oxidative stress protection, and studies in the upcoming years are likely to reveal how SOD1 activation pathways work to modulate cell signals involving superoxide and hydrogen peroxide.
